Published in

Taylor and Francis Group, Leukemia & Lymphoma, 9(62), p. 2288-2291, 2021

DOI: 10.1080/10428194.2021.1913141

Links

Tools

Export citation

Search in Google Scholar

Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center

Journal article published in 2021 by Cecilia Carpio ORCID, Gloria Iacoboni, Guillermo Villacampa ORCID, Eva Catalá, Sabela Bobillo, Ana Pérez, Moraima Jiménez, Laura Segura, Mireia Olivé, Anna Farriols, Pau Abrisqueta, David Valcárcel ORCID, María Josep Carreras, Francesc Bosch ORCID, Pere Barba ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO